Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and CyclophosphamidePaola Papaldo, F. Calabresi, Claudio Botti et al.|Journal of Clinical Oncology|2005Cited by 96
Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and CyclophosphamidePaola Papaldo, Paolo Marolla, Massimo Lopez et al.|Journal of Clinical Oncology|2003Cited by 76
Does Granulocyte Colony-Stimulating Factor Worsen Anemia in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide?Paola Papaldo, Francesco Cognetti, G. Ferretti et al.|Journal of Clinical Oncology|2006Cited by 42
Breast cancer and timing of surgery during menstrual cycle: a 5‐year analysis of 248 premenopausal womenMichele Stanislaw Milella, Paola Papaldo, Cecilia Nisticò et al.|Breast Cancer Research and Treatment|1999Cited by 17
Gemcitabine/cisplatin in advanced transitional cell carcinoma of the urinary tract (TCC): a phase II multicenter trialS. Mancarella, M. De Lena, Vito Lorusso et al.|European Journal of Cancer|1999Cited by 4